Introduction
A highly specialized type of cell-cell interaction is fusion between plasma membranes. Cell-cell fusion occurs between cells of the same type (homotypic reactions) as weU as between cells of different types (heterotypic reactions). Homotypic cell fusion reactions include fusion of myoblasts to form myotubes, fusion of monocytes to form osteoclasts, and fusion of cytotrophoblasts to form the placental syncytiotrophoblast The products of homotypic ceU fusion reactions are multinucleated cells that perform specialized functions. Heterotypic cell fusion reactions occur between gametes. In all cases, cell-cell fusion reactions lead to profound physiological and developmental changes.
Cell-cell fusion reactions are highly regulated. It is irnperative that cells fuse only when the environment is correct for their further differentiation and function. It is equally important that ceU fusion events be highly specilic (i.e. that the fusing partners be of the correct ceU type).
Although some of the proteins that regulate and dictate the target specificity of ceU fusion reactions have been identified, the actual molecular basis of fusion remains elusive. Since enveloped viruses use specific proteins to mediate their essential membrane fusion reactions, we will lirst review what is known about viral membrane fusion proteins. We will then propose and discuss a working hypothesis regarding the possible role of proteins in cell-cell fusion reactions. For more comprehensive recent reviews on this topic see those by Stegmann et al [l] and White (Annu Rev P&siol, in press).
The viral paradigm
Enveloped viruses infect cells by fusing with cellular membranes. Viral fusion events share an important feature in common with cell-cell fusion reactions. Both processes are 'exoplasmic' (Fig. 1) ; the exoplasmic (outer) 1eaIlets of the fusing bilayers make initial contact. This is in contrast to 'endoplasmic' fusion events such as the fusion of transport vesicles carrying material be-tween intracellular organeUes. During the latter reactions, the endoplasmic (cytoplasmic) leatlets make initial contact. For a recent review focused on endoplasmic fusion reactions, see that by Wiischut (Curt-Opin Cell Biol 1989,1:63%47) .
Given the differences in the exoplasmic (extracellular) and endoplasmic (cytoplasmic) environments, the mechanisms and proteins involved in exo-and endoplasmic fusion events may dilfer substantially. Conversely, since cell-cell and virus-cell fusion reactions are exoplasmic, they may share principles in common.
Viral membrane fusion proteins
Two virally encoded activities are necessary for an enveloped virus to enter its host cell. The first is a specific binding interaction between a viral protein and a host cell receptor; the second is the fusion event itself. For paramyxoviruses (e.g. Sendai), these two functions are contained within separate spike glycoproteins; the 'I-IN' (hemagglutin/neu raminidase) glycoprotein mediates binding while the 'F' (fusion) glycoprotein mediates fusion. For other viruses (e.g. influenza), the binding and fusion functions reside in the same glycoprotein; however, in these bifunctional proteins, the binding and fusion domains are physically distinct (Table 1 and Fig. 2a, b) . We believe that the important segregation of binding and fusion functions observed in enveloped viruses will be reiterated in cellular fusion reactions.
The membrane fusion proteins from members of over 25 different virus genera have now been identified, cloned and sequenced. All that have been analyzed further are oligomeric class I integral membrane proteins in which most of the amino acids (>85%) are external to the virus membrane. Most contain N-linked carbohydrates and many are fatty-acylated. They are present -at high density in the viral membranes (e.g. -3 x lO*/umz on influenza). Despite these general similarities, the fusion proteins difler in many important respects (Table 1) .
Viral fusion proteins can be classified into one of two major categories according to whether they do or do not require exposure to low pH in order to function. Viruses bearing low pH-activated fusion proteins, such as influenza, are taken into cells by receptor-mediated endocytosis and fuse when they reach an endosome of appropriately low pH (pH 5-6.5, depending on the particular virus). Conversely, viruses whose fusion proteins function at neutral pH, such as the human immunodeliciency virus, are believed to fuse directly with the plasma membrane. Within these two broad groups, the viral fusion proteins can be further subdivided according to whether or not they possess an identifiable 'fusion peptide'.
Fusion peptides are currently defkd as stretches of apolar amino acids (in addition to the transmembrane domain) that are conserved within but not between virus families. A feature we believe to be functionally important is that all fusion peptides are located in a polypeptide chain which is anchored in the viral membrane ( Fig.  2a ). Most fusion peptides are found at the amino terminus of the membrane-anchoring chain, whereas several are found internal to the amino terminus. Although prevalent, fusion peptides have not been identified in all viral membrane fusion proteins ( Table 1) . Most of the known fusion proteins are made as larger precursors and then cleaved, late in their biosynthetic pathway, into two polypeptide chains that remain associated through disulfide bonds and/or non-covalent interactions. For most of the cleaved fusion proteins, including those with aminoterminal [e.g. the influenza hemagglutinin (HA)], internal (e.g. the env glycoprotein of Rous sarcoma virus), and no obvious fusion peptide (e.g. the coronavirus E2 protein), processing appears to be essential for fusion function (Table 1) .
Our understanding of how a viral protein promotes fusion is most detailed in the case of the influenza HA, largely because the crystal structure of this molecule is known. The collective findings suggest the following sequence of events: Upon exposure to mildly acidic pH, the trimeric HA spike undergoes a conformational change. and the three fusion peptides are liberated from the trimer interface (Fig. 2b) .The fusion peptides then interact with lipids of the target membrane. In this manner, the fusion protein is thought to associate simultaneously and hydrophobically with both the viral and target membranes, leading to the production of a non-bilayer structure at the contact site (Fig. 2c ), a necessary intermediate in the fusion process. Although other viral fusion proteins appear to undergo conformational changes and express hydrophobic moieties under fusion-inducing conditions, we do not yet know whether the fusion mechanism of the HA can be generalized to other viral proteins. We anticipate that the various viral membrane fusion proteins will exhibit interesting variations on the HA theme, and possibly unexpected mechanisms. 
Identification of proteins involved in cell-to-cell fusion
For simple viruses such as influenza and Sendai, the hrsion function resides in a single oligomeric spike glycoprotein. For these viruses, assignment of the fusion function has been relatively straightforward, involving demonstration of fusion activity following either expression of the cloned gene encoding the fusion protein or reconstitution of the purihed fusion protein into artilicial vesicles. Identification of the fusion proteins of more complex viruses has proved more difficult. For herpes simplex virus, which expresses seven distinct glycoproteins, three of them, gB, gD and gH, may be required for optimal fusion. Given the enhanced complexity of cellular membranes, it is therefore fully expected that identilication of proteins involved in cell-cell fusion will be a challenging task. Of the known cell-cell fusion reactions, the two that have been investigated most intensely are myoblast fusion and gamete fusion. Therefore, in the ensuing discussion we will focus on these two cell-cell fusion processes. After discussing proteins that determine the specificity and regulation of these events, we will discuss proteins that have been implicated in reactions more proximal to the final membrane joining.
Proteins involved in myoblast fusion
Knudson and Horwitz (D~LJ Biol1977, 58:328-338; Dev Biol 1978, 66:294-307) proposed that myoblast fusion be considered a sequence of events: cell-cell recognition and adhesion, and then membrane fusion. As in the viral systems, the binding and fusion steps are biochemically separable events. Specidc cell surface molecules are certainly required to provide for the close adhesion and cell type speci.hcity required for myoblast fusion. Two types of cell adhesion systems have been described for both avian (Gibralter and Turner, Dev Biof 1985, 112:292-307 ; Knudson, J cell Biol 1985, 101:891-897) and mammalian [4] myo-blasts: a calcium-dependent system and a calcium-independent system. Both classes of interactions involve glycoproteins and both may employ multiple components, Likely participants in calcium-independent myoblast adhesion are one or more variants of the neural cell adhesion molecule (NCAM). This prediction derives from the observation of both qualitative and quantitative changes in the expression of various NCAM isoforms during myogenesis. Interestingly, the levels of phosphatidylinositol (PI)-linked NCAM(s) increase during myogenesis in VirrO (Moore et uL, J cell Bill 1987 ,105:1377 -1386 and treatment of myoblasts with PI-specific phosphollpase C interferes with myoblast adhesion (Knudson et uL, J Cell Biol, in press ). In terms of calciumdependent myoblast adhesion, one or more members of the cadherin family (see Kemler et al, this issue, pp 892-897) are likely to be involved. Many factors that appear to be inhibitors of myoblast fusion are actually inhibitors of differentiation. For example, a monoclonal antibody against chicken integrin, the extracellular matrix receptor, prevents myoblast fusion by preventing differentiation (Menko and Boettiger, Cell 1987, 51:51-57) . This observation, which in its own right is sign&ant and intriguing, highlights an important experimental point. In assessing the effects of inhibitors of myoblast fusion, it is important to determine whether di@erentiation or a process more directly involved in I%sion has been blocked. An additional complication is that myoblast differentiation consists of at least two separable stages, commitment,which Is reversible, and terminal differentiation which is not reversible and which, apparently, begins with the onset of fusion 151. Therefore it would be expected that a fusion inhibitor would block terminal differentiation without blocking commitment. Several factors have been implicated as regulators of myoblast fusion. Calcium figures prominently in this context Calcium inilux is known to precede membrane fusion (David et al, Dev BioZl981, , and low concentrations of calcium prevent fusion without blocking myoblast differentiation. Calcium channels, such as the embryonic acetylcholine receptor [6], or a recently described stretch-activated Ca*+-channel that is most active when myoblasts are fusing (Franc0 and Lansman, Bi@vs J 1989,55:491a), are thought to mediate the Ca2+ inlkrx. The mechanism by which Ca*+ influx eventually leads to membrane fusion is unclear. Given that prostaglandins Cell L&f 1988, 22:245-258) . Although a soluble metalloendoprotease has been implicated in myoblast fusion (Strittmatter et aL, 19871 , neither the precise step(s) at which it acts (Baklwin and Ka$er, Proc Nutf Acad Sci 1%4 1986,83:80298033) nor its substrates have been identified. Proteins that maintain lipid asymmetry may be important determinan ts of the fusogenic capacity of membrane surfaces. The exoplasmic leailet of chick (but not rat) myoblast plasma membranes contains two to three times more phosphatidylethanolamine (PE) and phosphatidylserine (PS) than the exoplasmic leaflets of iibroblast or erythrocyte plasma membranes. Although this enrichment cannot account in total for the fusogenic property of the myoblast surface, it may play an indirect role (Sessions and Horwitz, Biocbim Bic@ys Actu 1983, 728:103-111) . In this context it is interesting that an ATPase has recently been described which maintains a relatively high amount of PS in the endoplasmic leaflet of chromaffin granules [8] . It will be interesting to see whether chick myoblasts use related mechanisms to maintain relatively high amounts of PS and PE in their fusing surfaces.
Proteins involved in gamete fusion
Gamete fusion is clearly an important cell-cell fusion reaction. It is under study in both lower and higher eukaryotes using a combination of genetic, immunological and biochemical approaches. Clues to some of the proteins involved in gamete binding and fusion are beginning to emerge.
In the baker's yeast Saccharomyces cerevistie two genes, FUSl and FUS2, have been identified whose products are involved in gamete fusion (McCaffrey et al, Mol Cell Biol 1987 , 7:2680 -2690 Trueheart et al, Mol Cell Biol 1987, 23162328) . Fusl is an 80kD integral membrane protein which localizes to the gamete attachment site. It has a relatively small extracellular domain with multiple Olinked carbohydrates, a single transmembrane domain, and a relatively large cytoplasmic domain. Characterization of FUS2 is in progress. Future studies are necessary to determine whether either or both of these proteins are involved in breakdown of the ceU wall, in binding the plasma membranes of cells of opposite mating types or in the final membrane fusion reaction. A polyclonal antibody blocking approach has been used in preliminary studies of mating in Dictyostelium discoiukum. Based on adsorption of the fusion-inhibitory activity of a polyclonal antiserum, a protein in the 70kD range has been implicated in a post-aggregation step required for gamete union [9] .
In sperm-egg fusion in higher eukaryotes the initial binding and the fusion reaction are clearly separate events. ~nitial binding occurs between acrosome-intact sperm and the extracellular glycoprotein coat of the egg, the zona pellucida. Sperm and egg proteins involved in this critical binding interaction have recently been identilied and characterized (Shur, this issue, pp 905-912). Following binding to the tona pellucida, sperm undergo the acrosome reaction and migrate toward the egg plasma mem-brane. Once the sperm and egg plasma membranes meet, the fusion reaction occurs. The zona pellucida of the egg can be removed such that binding and fusion between (fully differentiated) sperm and egg plasma membranes can be investigated in vitro. Various types of perturbants have been used to begin to identify proteins involved in these events. Protease digestion experiments suggest that proteins on the mouse egg plasma membrane may be required for sperm binding [lo] . Monoclonal antibodies have been used to probe the molecular basis of sperm-egg fusion [ 111 (Saling et al, . Based on these studies, we feel that a good candidate to play a role in sperm-egg fusion is PH-30, a complex of two proteins located in the posterior head region of guinea pig sperm, a region where fusion with the egg occurs. Of two monoclonal antibodies that react with PH-30, one inhibits fu sion whereas the other does not. Neither antibody prevents binding between acrosome-reacted sperm and eggs whose zonae pellucidae have been removed (Primakoff et aL, J Cell Biol 1987, 104:141-149) . Interestingly, inhibitors of metalloendoproteases have been shown to block fusion of sea urchin sperm [ 1 l] and human sperm [12] with eggs. As is the case for myoblasts, the substrates of the implicated metalloendoproteases are not yet known.
Perspectives
Given the energy barrier to fusion we believe that all cellular fusion reactions are, at some level, protein-mediated. More specifically, we speculate that cellular fusion reactions are mediated by membrane fusion proteins. Until proven otherwise we adhere to a rather strict definition of a membrane fusion protein as a protein (or protein assembly) that interacts with lipid components of two apposed bilayers so as to bring about their unification. To date several proteins have been implicated in cell-cell fusion reactions. However, the precise role of any of these candidates in the overall fusion process remains to be determined. Since cell-cell fusion reactions are exo-plasm@ it is tantalizing to speculate that proteins involved in cell-cell fusion events will resemble viral membrane fusion proteins. However, lacking any evidence, at this point in time we must consider alternative possibilities. For example, it has been suggested that lysin, a soluble protein from the acrosome granule of abalone sperm, may play a direct role in fusion (Hong and Vacquier, Biocbemisty 1986, 25:543549) . It is also conceivable that phospholipid modifying-enzymes may play an active role in fusion.
In conclusion, we feel that the most pressing questions in the field of cell-cell fusion are the following: (1) Do specific proteins mediate cell-cell fusion reactions? (2) If so, do cell-cell fusion proteins share structural features in common with viral membrane fusion proteins? (3) If speciiic proteins mediate cell-cell fusion reactions, do they function like viral membrane fusion proteins, or
